Your session is about to expire
← Back to Search
CARE-CITE Gait for Stroke
N/A
Waitlist Available
Led By Sarah Blanton, PT, DPT
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 week post-intervention, 1 month follow up post-intervention
Awards & highlights
Study Summary
This trial will test a new method of stroke rehabilitation that involves the care partner, to see if it leads to better outcomes.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 1 week post-intervention, 1 month follow up post-intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 week post-intervention, 1 month follow up post-intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Carepartner satisfaction
Carepartners adherence rate
Change in Post-Study System Usability Questionnaire (PSSUQ)
+3 moreSecondary outcome measures
Change in Bakas Caregiving Outcomes Scale (BCOS) Score
Change in Caregiver Strain assessed by the Caregiver Strain Index (CSI)
Change in Family Care Climate Questionnaire - Carepartners (FCCQ-CP) Score
+7 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: CARE-CITE GAIT Stroke SurvivorExperimental Treatment1 Intervention
This study arm consists of stroke survivors (SS) of carepartners receiving the CARE-CITE Gait intervention. Over a period of one month, along with the CP, the SS will receive 2 two-hour home-based therapy visits with a licensed physical therapist to develop therapy goals related to gait, mobility and balance and develop a home exercise plan to improve function.
Group II: CARE-CITE GAIT CarepartnerExperimental Treatment1 Intervention
This study arm consists of carepartners (CP) receiving the CARE-CITE Gait intervention. Over a period of one month, alongside the stroke survivor, the CP will receive 2 two-hour home-based therapy visits with a licensed physical therapist to develop therapy goals related to gait, mobility and balance and develop a home exercise plan to improve function. The CP will receive two additional phone calls to discuss the online CARE-CITE educational modules.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CARE-CITE Gait
2022
N/A
~40
Find a Location
Who is running the clinical trial?
Foundation for Physical Therapy, Inc.Industry Sponsor
12 Previous Clinical Trials
466 Total Patients Enrolled
Emory UniversityLead Sponsor
1,636 Previous Clinical Trials
2,560,541 Total Patients Enrolled
28 Trials studying Stroke
347,980 Patients Enrolled for Stroke
Sarah Blanton, PT, DPTPrincipal InvestigatorEmory University
1 Previous Clinical Trials
46 Total Patients Enrolled
1 Trials studying Stroke
46 Patients Enrolled for Stroke
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
Georgia
How old are they?
18 - 65
What site did they apply to?
Emory Hospital
What portion of applicants met pre-screening criteria?
Met criteria
Share this study with friends
Copy Link
Messenger